Electromed

Electromed CapEx/D&A

CapEx to Depreciation Ratio of Electromed (ELMD) as of Oct 17, 2026.

CapEx/D&A

-

Last updated:

CapEx to Depreciation Ratio of Electromed is 2026 - . CapEx to Depreciation Ratio of Electromed was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Electromed Stock analysis

What does Electromed do? Electromed Inc., headquartered in New Prague, Minnesota, develops, manufactures, and sells medical equipment specializing in High Frequency Chest Wall Oscillation (HFCWO) technology for pulmonary care. The company offers the SmartVest Clearway System, including an inflatable therapy garment and air pulse generator, alongside SmartVest Connect, a wireless therapy management portal. It also markets Single Patient Use SmartVest products for acute care settings. Electromed employs 177 full-time staff and has been listed since August 13, 2010. Electromed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Electromed stock

On Eulerpool you can find the complete historical development of CapEx to Depreciation Ratio Electromed since 2006 – with annual values, charts, and detailed analysis.

The CapEx/D&A ratio compares investment spending to asset depreciation. Ratios above 1.0x indicate the company is growing its asset base, below 1.0x suggests underinvestment.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Depreciation Ratio's Electromed with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Depreciation Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Depreciation Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Electromed

All Key Metrics — Electromed